Daily BriefsECM

Daily Brief ECM: Tekscend Photomask (429A JP) IPO: Trading Debut and more

In today’s briefing:

  • Tekscend Photomask (429A JP) IPO: Trading Debut
  • SANY Heavy Industry H Share Listing: The Investment Case
  • TOP TOY IPO: From China To The World — Rapid Growth and Solid Profitability Under MINISO Group
  • Chando Global Pre-IPO Tearsheet
  • Tekscend Photomask IPO Trading – Priced at the Top, but Still Relatively Cheap
  • Xuanzhu Biopharm  (轩竹生物科技) IPO: Trading Updates
  • JST Group Pre-IPO: Premium to Peers but Potentially a Domestic “Shopify”
  • Sany Heavy Industries A/H Listing – PHIP Updates and Thoughts on A/H Premium
  • Pre-IPO Shanghai MediTrust Health Technology Group – The Business Model and the Concerns Behind
  • Exzeo Group, Inc. (XZO): Peeking at the IPO Prospectus of an Insurance Technology Platform Company


Tekscend Photomask (429A JP) IPO: Trading Debut

By Arun George


SANY Heavy Industry H Share Listing: The Investment Case

By Arun George

  • Sany Heavy Industry (600031 CH), the world’s third-largest construction machinery company, has filed its PHIP for an H Share listing to raise US$1.0-1.5 billion.     
  • SANY has six operating segments. The largest segment, as measured by revenue and gross profit, is excavating machinery.
  • The fundamentals are good, with strong growth, an increasing overseas mix, an improving margin profile, strong cash generation, and a solid balance sheet. 

TOP TOY IPO: From China To The World — Rapid Growth and Solid Profitability Under MINISO Group

By Andrei Zakharov

  • TOP TOY International Group Limited, a world-class pop toy brand company from China, filed to go public in Hong Kong.
  • Founded in 2020, the brand has quickly positioned itself as a domestic rival to China’s Pop Mart, capitalizing on the country’s booming “blind box” and designer toy craze.
  • TOP TOY has shown strong growth and execution, going from RMB641m in sales of pop toy products in 2022 to RMB2,554m expected this year.

Chando Global Pre-IPO Tearsheet

By Akshat Shah

  • Chando Global Limited (CHANDO HK) is looking to raise at least US$500m in its upcoming Hong Kong IPO. The deal will be run by Huatai International and UBS.
  • Chando Global is a multi brand cosmetics company in China. It was China’s third-largest domestic cosmetics group, by retail sales in 2024, according to Frost & Sullivan (F&S).
  • Its flagship brand, CHANDO, had consistently ranked among the top two domestic cosmetics brands for 12 consecutive years from 2013 to 2024 by retail sales.

Tekscend Photomask IPO Trading – Priced at the Top, but Still Relatively Cheap

By Sumeet Singh

  • Tekscend Photomask (429A JP), a manufacturer and distributor of semiconductor photomasks, raised around US$900m in its Japan IPO.
  • TP is a global provider of photomasks and related support services. It has been the leader in the merchant photomask market in terms of sales since 2016.
  • In our previous note, we looked at its past performance and valuations. In this note, we will talk about the trading dynamics.

Xuanzhu Biopharm  (轩竹生物科技) IPO: Trading Updates

By Ke Yan, CFA, FRM

  • Xuanzhu raised HKD 781m (USD 100m) from its global offering and will list on the Hong Kong Stock Exchange on Wednesday, October 15, 2025.
  • In our previous note, we looked at the company’s operation, management track records and discussed the IPO valuation.
  • In this note, we provide an update for the IPO before trading debut.

JST Group Pre-IPO: Premium to Peers but Potentially a Domestic “Shopify”

By Nicholas Tan

  • JST Group (1703609D CH) is looking to raise up to US$270m in its upcoming Hong Kong IPO.
  • It is China’s largest and most popular e-commerce SaaS ERP provider. 
  • In this note, we examine the IPO dynamics, and look at the firm’s valuation.

Sany Heavy Industries A/H Listing – PHIP Updates and Thoughts on A/H Premium

By Sumeet Singh

  • Sany Heavy Industry (600031 CH), aims to raise around US$1.5bn in its H-share listing.
  • Sany Heavy Industry was the world’s third largest and China’s largest construction machinery company in terms of construction machinery’s cumulative revenue from 2020 to 2024, according to Frost & Sullivan.
  • We have looked at the company’s past performance in our earlier note. In this note, we talk about the updates and likely A/H premium.

Pre-IPO Shanghai MediTrust Health Technology Group – The Business Model and the Concerns Behind

By Xinyao (Criss) Wang

  • The essence of MediTrust’s business model is building an ecosystem of “Internet/AI + drugs + medical services + insurance”. The core competitiveness lies in the network effect of medical payments.
  • Smart Pharma Solution overly relies on pharmaceutical companies’ promotion budgets and is susceptible to the impact of industry policies. Smart Insurance Solution is facing the industry dilemma of poor profitability.
  • Post-Money valuation after Series C+ financing is RMB11.68bn. Based on 2024 revenue of RMB2.035bn, P/S is 5.7x. We think valuation of MediTrust should be lower than Ping An Good Doctor

Exzeo Group, Inc. (XZO): Peeking at the IPO Prospectus of an Insurance Technology Platform Company

By IPO Boutique

  • HCI has announced plans to spin off Exzeo as a standalone entity which is their insurance technology solutions company
  • Through the Exzeo Platform, they currently provide services in 13 states in which their customers have operations.
  • They had revenue of $45.6 million, $88.3 million, and $133.9 million and income (loss)  after taxes of ($42.0 million), $12.9 million, and $26.1 million in 2022, 2023, and 2024, respectively.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars